Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Apyx Medical CorpAPYX · Entity 6609 | Executive Vice President | January 10, 2024 | January 11, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Apyx Medical Corp
Report date January 10, 2024 · Filed January 11, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Option to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.42 · Expires 2034-01-10 | Direct | 0 |
Reported balance
After 2024-01-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-01-10 · Grant · Acquired 100,000 · Balance 0 F1: Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 10, 2024 Filed Jan 11, 2024 21:05 UTC | Apyx Medical Corp APYX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 100,000 | $0.00 Strike: $2.42 | $0.00 |
DisclosureSEC source: 0001493152-24-002056 · ownership.xml · derivative · entry 1 Hornsby Todd · CIK 0001764505 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2034-01-10 F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant. Read SEC document |
| June 26, 2023 Filed Jun 28, 2023 18:01 UTC | Apyx Medical Corp APYX · Entity 6609 | Exercise / conversionStock Option (Option to Buy) · Derivative | 15,000 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0000719135-23-000036 · wk-form4_1687975277.xml · derivative · entry 3 Hornsby Todd · CIK 0001764505 · Executive Vice President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2025-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 26, 2023 Filed Jun 28, 2023 18:01 UTC | Apyx Medical Corp APYX · Entity 6609 | SaleCommon Stock | 15,000 | $7.56 | $113,400.00 |
DisclosureSEC source: 0000719135-23-000036 · wk-form4_1687975277.xml · nonDerivative · entry 2 Hornsby Todd · CIK 0001764505 · Executive Vice President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40 F1 · kind: The reported sale occurred automatically pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on March 21, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $7.30 to $7.70. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 26, 2023 Filed Jun 28, 2023 18:01 UTC | Apyx Medical Corp APYX · Entity 6609 | Exercise / conversionCommon Stock | 15,000 | $1.77 | $26,550.00 |
DisclosureSEC source: 0000719135-23-000036 · wk-form4_1687975277.xml · nonDerivative · entry 1 Hornsby Todd · CIK 0001764505 · Executive Vice President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 26, 2023 Filed Jun 29, 2023 20:42 UTC Amendment | Apyx Medical Corp APYX · Entity 6609 | Exercise / conversionStock Option (Option to Buy) · Derivative | 15,000 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0000719135-23-000040 · wk-form4a_1688071316.xml · derivative · entry 3 Hornsby Todd · CIK 0001764505 · Executive Vice President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 15,000 shares Expires 2025-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 26, 2023 Filed Jun 29, 2023 20:42 UTC Amendment | Apyx Medical Corp APYX · Entity 6609 | SaleCommon Stock | 15,000 | $7.56 | $113,400.00 |
DisclosureSEC source: 0000719135-23-000040 · wk-form4a_1688071316.xml · nonDerivative · entry 2 Hornsby Todd · CIK 0001764505 · Executive Vice President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The reported sale occurred automatically pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on March 21, 2023 F2 · price: This transaction was executed in multiple trades at prices ranging from $7.30 to $7.70. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F3 · balance_after: The original Form 4 is hereby amended to correct the amount of securities beneficially owned by the Reporting Person (as set forth in Column 5 of Table I) following the previously reported transactions Read SEC document |
| June 26, 2023 Filed Jun 29, 2023 20:42 UTC Amendment | Apyx Medical Corp APYX · Entity 6609 | Exercise / conversionCommon Stock | 15,000 | $1.77 | $26,550.00 |
DisclosureSEC source: 0000719135-23-000040 · wk-form4a_1688071316.xml · nonDerivative · entry 1 Hornsby Todd · CIK 0001764505 · Executive Vice President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 11, 2023 Filed Jan 13, 2023 21:18 UTC | Apyx Medical Corp APYX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 100,000 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0000719135-23-000006 · wf-form4_167364467757016.xml · derivative · entry 1 Hornsby Todd · CIK 0001764505 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2033-01-11 F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant. Read SEC document |
| January 19, 2022 Filed Feb 1, 2022 17:02 UTC | Apyx Medical Corp APYX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 100,000 | $0.00 Strike: $10.96 | $0.00 |
DisclosureSEC source: 0000719135-22-000012 · wf-form4_164373490876736.xml · derivative · entry 1 Hornsby Todd · CIK 0001764505 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-01-19 F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant. Read SEC document |
| January 29, 2021 Filed Feb 9, 2021 21:55 UTC | Apyx Medical Corp APYX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 50,000 | $0.00 Strike: $9.29 | $0.00 |
DisclosureSEC source: 0000719135-21-000010 · wf-form4_161290773178337.xml · derivative · entry 1 Hornsby Todd · CIK 0001764505 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-01-29 F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant. Read SEC document |
| January 15, 2020 Filed Jan 22, 2020 22:17 UTC | Apyx Medical Corp APYX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 100,000 | $0.00 Strike: $8.18 | $0.00 |
DisclosureSEC source: 0000719135-20-000010 · wf-form4_157973142556336.xml · derivative · entry 1 Hornsby Todd · CIK 0001764505 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-01-15 F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant. Read SEC document |
| January 09, 2019 Filed Feb 12, 2019 00:13 UTC | Apyx Medical Corp APYX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 76,000 | $0.00 Strike: $7.91 | $0.00 |
DisclosureSEC source: 0000719135-19-000012 · wf-form4_154993038675597.xml · derivative · entry 1 Hornsby Todd · CIK 0001764505 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,000 Underlying: Common Stock · 76,000 shares Expires 2029-01-09 F1 · derivative.exercise_price: Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant. F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.